MergerLinks - Laura Knoll

Cover Image Laura Knoll

Laura Knoll

Partner at Skadden Arps Slate Meagher & Flom

Lawyer

Boston

Deal Bio

Total Deals22

Valued Deals18

Total Value£83,637M

Avg. Deal Size£4,647M

Awards

2023 Top Female M&A Lawyers in North America

Sort

Real Estate Holding and Development

AcquisitionPrivateMajorityPrivate Equity

Wework Companies

target

Wework Companies

Softbank Group Corp

bidder

Softbank Group Corp

value n/a

16 dealmakers

Food Retailers and Wholesalers

AcquisitionMergerPublicMajority

Supervalu

target

Supervalu

United Natural Foods

bidder

United Natural Foods

£2,187m

57 dealmakers

Pharmaceuticals

MergerAcquisitionPublicMajorityDomestic

Array Biopharma

target

Array Biopharma

Pfizer

bidder

Pfizer

£9,049m

51 dealmakers

Pharmaceuticals

PublicAcquisitionMergerPrivate Equity

Alder Biopharmaceuticals

target

Alder Biopharmaceuticals

Lundbeck As

bidder

Lundbeck As

£1,559m

10 dealmakers

Cross BorderAcquisitionMajorityPublicTender Offer

Arqule

target

Arqule

Merck Kgaa

bidder

Merck Kgaa

£2,054m

62 dealmakers

Real Estate Holding and Development

Cross BorderPrivate EquityAcquisitionMajorityPrivate

Wework Companies

target

Wework Companies

Softbank Group Corp

bidder

Softbank Group Corp

£3,472m

33 dealmakers

PrivateMajorityAcquisitionPrivate EquityCross Border

Cersci Therapeutics

target

Cersci Therapeutics

Acadia Pharmaceuticals

bidder

Acadia Pharmaceuticals

£717m

20 dealmakers

DomesticAcquisitionMajorityPublic

Akcea Therapeutics

target

Akcea Therapeutics

Ionis Pharmaceuticals

bidder

Ionis Pharmaceuticals

£334m

36 dealmakers

Health Care Services

DomesticMajorityPrivateAcquisitionPrivate Equity

Refresh Mental Health Partners

target

Refresh Mental Health Partners

Kelso & Co

bidder

Kelso & Co

value n/a

13 dealmakers

PublicDomesticAcquisitionMajorityTender Offer

Pandion Therapeutics

target

Pandion Therapeutics

Merck & Co

bidder

Merck & Co

£1,308m

28 dealmakers

Real Estate Holding and Development

Reverse TakeoverMergerPrivate EquityAcquisitionDomesticPrivateMajorityDe-SPAC

Wework Companies

target

Wework Companies

Bow Capital

bidder

Bow Capital

£6,532m

107 dealmakers

MajorityCross BorderAcquisitionPublic

DICERNA

target

DICERNA

Novo Nordisk

bidder

Novo Nordisk

£2,452m

23 dealmakers

Payments / Commerce

PublicDomesticPrivatisationAcquisitionMajorityPrivate Equity

BOTTOMLINE

target

BOTTOMLINE

Thoma Bravo

bidder

Thoma Bravo

£1,956m

30 dealmakers

Health Care Services

DomesticMajorityPrivate EquityAcquisitionPrivate

Refresh Mental Health Partners

target

Refresh Mental Health Partners

Optum

bidder

Optum

value n/a

4 dealmakers

MajorityAcquisitionCross BorderPublicPrivate Equity

Cincor Pharma

target

Cincor Pharma

Astrazeneca

bidder

Astrazeneca

£1,487m

79 dealmakers

AcquisitionMajorityDomesticPublic

Seagen

target

Seagen

Pfizer

bidder

Pfizer

£35,705m

67 dealmakers

Cross BorderPublicAcquisitionMajority

Iveric Bio

target

Iveric Bio

Astellas Pharma

bidder

Astellas Pharma

£4,693m

22 dealmakers

AcquisitionMajorityCross BorderPublic

Intercept Pharmaceuticals

target

Intercept Pharmaceuticals

Alfasigma

bidder

Alfasigma

£649m

31 dealmakers

AcquisitionMajorityDomesticPublic

Mirati Therapeutics

target

Mirati Therapeutics

Bristol Myers Squibb Company

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

AcquisitionDomesticMajorityPrivate EquityPublic

ENGAGESMART

target

ENGAGESMART

Vista Equity Partners

bidder

Vista Equity Partners

£3,288m

48 dealmakers

MajorityDomesticPrivate EquityAcquisitionPrivate

EYEBIOTECH

target

EYEBIOTECH

Merck & Co

bidder

Merck & Co

£2,348m

23 dealmakers

Health Care Services

AcquisitionDomesticMajorityPrivatePrivate Equity

Jordan Health Services

target

Jordan Health Services

Kelso & Co

bidder

Kelso & Co

value n/a

12 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.